Clinical Guides
Attention-Deficit/Hyperactivity Disorder (ADHD)
An India-adapted, lifespan guide to developmental diagnosis, multi-informant assessment, functional support, cautious prescribing, monitoring, and transition of care for attention-deficit/hyperactivity disorder.
MedNext Academy | 15 min read
Attention-Deficit/Hyperactivity Disorder (ADHD)
An India-adapted, lifespan guide to developmental diagnosis, multi-informant assessment, functional support, cautious prescribing, monitoring, and transition of care for attention-deficit/hyperactivity disorder.
Summary
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder defined by a persistent, developmentally inappropriate pattern of inattention and/or hyperactivity-impulsivity that impairs functioning. Symptoms begin in the developmental period, occur across more than one important setting and cannot be explained better by another condition or circumstance. ADHD is not diagnosed from energetic temperament, poor marks, a rating-scale total, a brief consultation, a computer task, a brain scan or response to a stimulant. Presentation changes with age: overt motor activity may become inner restlessness, while planning, time management, emotional regulation and sustained effort become more visible as demands increase.
A valid assessment combines developmental and psychiatric history, the person's account, observer information from relevant settings, mental-state and physical assessment, educational or occupational function, and review of comorbidity. For children, parents and school are usual informants, but disagreement is clinically informative rather than a reason to average scores. For adults, evidence of childhood manifestations and current impairment should be explored without insisting on unavailable school records.
Management is individualised and multimodal. It may include psychoeducation, environmental adjustments, parent-focused support, school or workplace strategies, skills-based psychological intervention and medication initiated by a trained clinician when indicated. Medication choice depends on age, impairment, comorbidity, cardiovascular and other baseline findings, previous response, availability and preference. Titration targets meaningful benefit with tolerable harm; growth or weight, pulse, blood pressure, sleep, mood, tics, adherence, misuse and diversion require continuing review. This educational draft cannot diagnose an individual or authorise controlled-drug prescribing.
How Common Is It?
ADHD is among the more common neurodevelopmental disorders, but prevalence changes with age range, diagnostic system, impairment threshold, sampling, informants and access to assessment. The Indian Psychiatric Society guideline cites international school-age estimates around 5–7%; that range should not be misrepresented as a current national Indian prevalence. School surveys, clinic samples and parent questionnaires answer different questions. A positive screen estimates symptom burden, while a specialist diagnosis requires developmental onset, cross-setting evidence, impairment and exclusion of better explanations.
Recognition is uneven. Children with disruptive hyperactive behaviour are more likely to be referred than quiet pupils whose main difficulty is attention, organisation or slow task completion. Girls, academically able young people, adults, rural families, people using a language without a well-validated scale, and those whose symptoms are masked by intensive family support may be identified late. Conversely, crowded classrooms, unsuitable teaching, sleep deprivation, adversity or a learning disorder can be mistaken for ADHD when the assessment is rushed. Better detection therefore means more accurate formulation, not simply more labels.
ADHD often continues beyond childhood, although symptoms and impairment can change. An adult may struggle with deadlines, driving, finances, relationships, education, parenting or occupational reliability rather than classroom conduct. Transition points expose difficulties when family scaffolding or school structure falls away. Service statistics undercount people who cannot access trained clinicians and over-represent complex referrals. A useful Indian service audit records waiting time, age and gender at referral, informants obtained, developmental and learning assessment, comorbidity, baseline physical measures, offered non-pharmacological support, medicine continuity and transition to adult care. It should measure function and adverse effects, not celebrate diagnosis or prescription volume alone.
Risk Factors
ADHD is strongly influenced by genetic and neurodevelopmental factors, yet no gene, family history or prenatal exposure determines an individual's diagnosis. A first-degree family history raises probability and can help explain differing expectations within a household. Prematurity, very low birth weight, selected prenatal and perinatal adversities, epilepsy, acquired brain injury and some genetic syndromes are associated with higher rates. Associations with pregnancy exposures must be discussed without blaming mothers or claiming causation from observational evidence. Ordinary parenting does not cause ADHD, although family routines and stress can affect how impairment is expressed and managed.
Clinical visibility depends on environment. Symptoms may become problematic when classroom size increases, work becomes less supervised, sleep shortens, family support changes or tasks demand sustained self-organisation. Inconsistent routines, violence, deprivation, bullying, digital overuse and chaotic study conditions can worsen attention or behaviour but may also be independent targets for help. Exposure to tobacco, alcohol or drugs, including during adolescence, requires a confidential and non-punitive assessment. Stimulant seeking for examination performance must not be equated automatically with ADHD.
Coexisting autism, intellectual disability, developmental language disorder, specific learning disorder, developmental coordination problems, tic disorder, anxiety, depression, bipolar disorder, oppositional or conduct problems, substance use and sleep disorders are common enough to seek actively. Physical contributors such as hearing or vision impairment, thyroid disease, anaemia, seizures and medicine effects may mimic or compound symptoms. In adults, trauma, sleep loss, depression, anxiety, substance use and unstable housing can dominate the presentation. Risk factors refine the assessment; they cannot replace proof of persistent symptoms, developmental onset, multiple settings and functional impairment.
Diagnosis
History
Build a developmental timeline rather than beginning with a checklist. Ask about early activity and attention, language, motor and social development, play, routines, school entry, learning, friendships, discipline, transitions and current demands. Establish examples of inattention and impulsivity, their frequency, context, persistence and consequences at home, education, work and relationships. Seek the person's own account and, with consent, parent, teacher, partner or employer observations. Review sleep, mood, anxiety, trauma, substance use, screen pattern, medicines, seizures, sensory problems, medical history, family history and safeguarding. Adult assessment must explore childhood manifestations but acknowledge that records or reliable relatives may be unavailable.
Examination
Observe engagement, activity, impulse control, speech, affect, thought, attention and developmental communication without treating clinic behaviour as a diagnostic test. A quiet child in an unfamiliar room may be impaired at school; an anxious adult may appear restless for another reason. Perform mental-state and risk assessment. Physical review should include height and weight in children, weight in adults, pulse, blood pressure and cardiovascular examination when medication is considered. Look for neurological, thyroid, sensory, genetic or developmental findings when the history indicates them.
Investigations
ADHD remains a clinical diagnosis. Rating scales can structure reports and monitor change but are not sufficient alone, especially when translated without validation. Obtain information from at least two relevant settings where feasible and examine why accounts differ. Review schoolwork, reports and learning assessment when appropriate. There is no routine diagnostic blood test, EEG, imaging or genetic panel. Order targeted tests only for a plausible alternative or comorbidity. Before medication, confirm the diagnosis and need, reconcile medicines, assess mental and social circumstances, substance misuse and diversion risk, measure physical baselines and complete a cardiovascular assessment. current guidelines does not require a routine ECG without specified cardiac features or another medicine that increases cardiac risk.
Differential Diagnosis
Normal developmental variation is the first boundary: expectations must match age, language, culture, opportunity, sleep and cognitive ability. A child may be inattentive only in a classroom where instruction is inaccessible, or restless during boredom, fear, hunger or prolonged sitting. Specific learning disorder can produce avoidance and apparent inattention during reading or mathematics. Intellectual disability, language disorder, hearing or vision impairment, autism and developmental coordination disorder may alter behaviour across settings. These conditions can coexist with ADHD, so identifying one does not automatically exclude the other.
Sleep deprivation, obstructive sleep apnoea, restless legs, circadian delay and irregular schedules can impair attention and impulse control. Anxiety may cause scanning and avoidance; depression can reduce concentration and motivation; trauma can produce hyperarousal or dissociation; mania causes an episodic change with mood and energy rather than a lifelong trait. Absence seizures, epilepsy, thyroid disorder, anaemia, pain, adverse medicine effects and substance intoxication or withdrawal need context-directed assessment. Oppositional behaviour may be situational or reflect frustration, while conduct disorder involves a different pattern of rights violations.
In adults, chronic disorganisation must be separated from a recent change caused by depression, anxiety, bereavement, burnout, sleep loss, substance use, cognitive disorder or medical illness. Personality traits alone do not establish developmental ADHD. Autism, learning disability and trauma can be missed in late-presenting adults, and compensatory strategies can obscure childhood impairment. Digital distraction is not a diagnostic category, though it may exacerbate symptoms. A stimulant response does not resolve the differential because wakefulness and task persistence can change in people without ADHD. Diagnostic humility is essential when childhood evidence is limited: record what supports, contradicts and remains unknown rather than manufacturing certainty.
Management
Begin with a shared formulation and goals stated in everyday function: completing morning routines, reducing dangerous impulsivity, participating in class, meeting work commitments, improving relationships or driving safely. Explain ADHD as a neurodevelopmental condition without presenting it as a fixed identity or excuse. Discuss strengths, preferences, stigma and comorbidity. Environmental modifications can include predictable routines, shorter instructions, reduced distraction, task chunking, visual schedules, movement opportunities, seating and written reminders. Adjustments should support access without lowering essential learning or safety standards.
For preschool children, evidence and guidelines place parent-training or other psychosocial intervention before medication in ordinary care, with specialist involvement for persistent severe impairment. For school-age children and adolescents, provide parent and educational support; medication may be offered by a trained clinician when impairment remains significant, alongside rather than instead of environmental change. Adults may benefit from medication, structured ADHD-focused psychological support, coaching of organisational skills and reasonable workplace adjustments according to availability and preference. Cognitive-behavioural approaches often target planning, procrastination, emotional responses and residual impairment rather than erasing core neurodevelopmental traits.
Treat important comorbidity and safeguarding needs in a coordinated sequence. Severe depression, mania, psychosis, substance dependence, self-harm risk or unstable medical disease can change urgency and drug choice. Monitor outcomes with patient-defined goals plus reports from relevant settings; a lower scale score without functional benefit is not enough. Review adherence, dosing schedule, sleep, appetite, growth or weight, pulse, blood pressure, mood, tics and adverse effects. Plan transition before paediatric care ends, specifying prescriber, monitoring responsibility and medicine supply. Periodically review whether benefits still outweigh harms and whether a supervised dose change or discontinuation trial is appropriate.
Prescribing Information
ADHD medicines should be initiated and titrated by a clinician trained in diagnosis and management, using current Indian product information, controlled-drug rules and local shared-care arrangements. Before treatment, reconfirm diagnosis and impairment; review psychiatric and neurodevelopmental comorbidity, current medicines, substance use, diversion risk and cardiovascular history; measure height and weight in children, weight in adults, pulse and blood pressure. Seek cardiology advice for the specific personal or family cardiac features described in guidance. Routine ECG or blood testing is not a substitute for a careful baseline and is not required without clinical indication.
Stimulants such as methylphenidate have strong evidence for core symptoms, but formulations differ in release profile, duration and misuse potential and are not milligram-for-milligram interchangeable. Atomoxetine is a non-stimulant option in defined pathways; other agents, age approvals and availability vary. Titrate against symptom and functional benefit, adverse effects and observations from more than one setting. Monitor growth in children, adult weight or body mass index when affected, appetite, sleep, pulse, blood pressure, behaviour, mood, tics, seizures and sexual adverse effects where relevant. New psychosis, mania, significant cardiovascular symptoms, suicidality or severe behavioural deterioration demands prompt clinical review.
Diversion is a patient-safety issue, not a moral label. Ask neutrally about sharing, selling, coercion, examination use, appetite suppression and substance history. Prefer formulations and supply arrangements that reduce risk when appropriate; do not prescribe easily misused preparations when diversion risk is substantial. Store controlled medicines securely and never share them. Evidence for long-term comparative outcomes, rare harms, ideal duration, supplements, restrictive diets and many digital or neurofeedback products remains limited or mixed. Medication does not teach academic skills, repair sleep deprivation or treat every comorbidity, and dose changes should never be copied from an educational page.
When to Refer
Children with persistent attention or behavioural problems causing at least moderate impairment should be referred to a paediatrician, child psychiatrist or appropriately trained ADHD service for diagnostic assessment. Severe impairment, major school exclusion risk, aggression, self-harm, safeguarding concern, developmental regression, seizures, psychosis or mania increases urgency. Primary-care recognition, physical screening and support can begin, but an initial diagnosis or medicine start should not be made by an untrained clinician. Refer for formal hearing, vision, language, cognitive or learning assessment when the history points to those needs.
Adults without a childhood diagnosis need specialist assessment when typical manifestations began during development, persist, are not better explained by another disorder and produce meaningful occupational, educational, social or psychological impairment. A prior childhood diagnosis does not remove the need to assess current symptoms, function, comorbidity and treatment. Transition should be planned in advance rather than ending prescriptions abruptly on a birthday. Identify who will prescribe, who will monitor physical parameters, how records and consent move, and what happens if the adult service lacks capacity.
Refer or seek additional advice for an uncertain diagnosis; marked informant discrepancy; autism, intellectual disability or complex learning problems; significant substance use or diversion; treatment resistance; intolerable adverse effects; pregnancy planning or pregnancy; complex cardiovascular disease; or recurrent non-adherence driven by access. Cardiology referral is indicated for specified symptoms or history before medication and for clinically significant abnormalities during treatment. Urgent medical or psychiatric referral supersedes the ADHD pathway when there is chest pain, exertional syncope, sustained severe tachycardia, psychosis, mania, suicidal intent, serious overdose or immediate danger.
Red Flags
ADHD itself is not usually an emergency, but the presenting situation may be. Immediate assessment is needed for active suicidal intent, a serious recent self-harm act, threats with capability, psychosis, mania, severe intoxication or withdrawal, delirium, abuse, exploitation or a child who cannot be kept safe. Dangerous impulsivity may present as repeated running into traffic, unsafe driving, fire-setting, weapon access, high-risk sexual behaviour or escalating violence. Do not attribute these events to ADHD without assessing mood disorder, trauma, substance use, safeguarding and acute medical causes.
During medication treatment, chest pain, exertional fainting, sustained palpitations with physiological compromise, severe headache with marked hypertension, seizure, collapse, acute psychosis, mania, severe agitation, allergic reaction or suspected overdose requires urgent clinical evaluation. New tics, appetite loss, insomnia or modest pulse change are not automatically emergencies, but they warrant timely prescriber review and objective measurement. Atomoxetine and other medicines require monitoring for important psychiatric or physical adverse effects according to their current label. Never advise abrupt improvised switching between formulations or use another person's medicine.
Diversion, coercion and misuse require a safety response. Ask whether classmates, relatives, employers or partners pressure the person to share tablets; assess substance use, debt, violence and secure storage. A lost prescription pattern may reflect disorganisation, theft, trafficking or unstable housing and needs careful, non-accusatory review. For a child, sudden academic decline, school refusal, injuries, sexualised behaviour, unexplained fear or medication administered as punishment should trigger safeguarding assessment. The clinician should stabilise immediate risk first, then revisit diagnosis and treatment. A rating scale or routine follow-up appointment must never delay emergency care.
Indian Clinical Context
Indian assessment must work across multilingual families, large classrooms, variable teacher access, examination pressure and uneven specialist services. Obtain school information with parent and child knowledge and appropriate consent; explain why it is needed and protect the child from unnecessary disclosure. A teacher report is valuable but not infallible, and some schools cannot provide structured scales. Review notebooks, report cards, tutoring behaviour and observations from another setting when direct teacher feedback is unavailable. Translated scales without local validation should be labelled as aids, not diagnostic instruments. Joint-family members can add developmental information, while the patient remains central and confidentiality becomes especially important in adolescence and adulthood.
Learning disorders, language mismatch, hearing or vision problems, sleep deprivation from travel or coaching, bullying and unrealistic academic demands may be mistaken for ADHD or coexist with it. Support should include practical classroom and home changes rather than only a certificate or tablet. Parent training and psychological interventions may be scarce or unaffordable; clinicians can use structured psychoeducation and link families to credible local services, but should not claim that an unavailable therapy was offered. School accommodations and disability entitlements depend on current rules and institutional processes and must be checked, not promised.
Methylphenidate formulations, non-stimulants, pharmacy stock, price and controlled-drug procedures vary. Verify the current Indian label and legal requirements at each prescription; overseas sequencing cannot simply be copied. Prescribing without reliable follow-up is unsafe. Measure baselines with calibrated equipment, document the monitoring owner, and plan for travel or supply interruptions without stockpiling or sharing. Adult ADHD expertise and transition pathways may be limited, so paediatric and adult services should agree a written handover. The Indian Psychiatric Society child-adolescent guideline is an important local framework but does not cover adult needs fully; adult recommendations therefore require specialist lifespan evidence and transparent limits.
NMC Competency Mapping
ADHD links paediatrics, psychiatry, physiology, pharmacology, community medicine, family medicine and AETCOM. Within the NMC Competency Based Medical Education Curriculum 2024, learners should understand normal development before labelling pathology, take a developmental and behavioural history, assess school and family function, perform an age-appropriate mental-state and physical examination, and recognise common neurodevelopmental and psychiatric comorbidity. They should distinguish screening from diagnosis and explain why symptoms must be persistent, impairing and present in more than one setting.
A supervised clinical task can require separate examples from the child or adult, parent and teacher or partner, followed by a formulation that records agreement, discrepancy and missing information. Learners should generate developmental, learning, sensory, sleep, mood, anxiety, trauma, substance and medical alternatives. Communication competence includes explaining that ADHD is neither poor parenting nor a laboratory-confirmed disease, obtaining consent for school contact, protecting adolescent confidentiality, setting functional goals and avoiding stigma. Risk assessment includes self-harm, aggression, exploitation, unsafe driving and diversion.
Pharmacology competence includes broad stimulant and non-stimulant principles, baseline cardiovascular and growth measures, monitoring, interactions and controlled-medicine stewardship. Students should know that parent-focused and environmental interventions are central, particularly in younger children, and that medication is not a substitute for educational support. Curriculum mapping does not authorise an undergraduate to diagnose independently, prescribe a controlled drug, promise school concessions, conduct unsupervised psychotherapy or manage a crisis alone. Assessment should reward uncertainty, safe referral and longitudinal review rather than memorisation of a proprietary scale or one international dosing schedule.
Key Exam Pearls for NEET PG
ADHD is a neurodevelopmental, not an episodic, disorder. Core domains are inattention and hyperactivity-impulsivity; symptoms are developmentally inappropriate, persistent, impairing and evident in at least two important settings. Childhood onset is required, although recall and documentation may be incomplete in adults. A rating scale supports but does not make the diagnosis, and clinic observation alone can mislead. Always assess function and exclude better explanations. High-yield differentials include learning disorder, intellectual disability, autism, anxiety, depression, mania, trauma, sleep disorder, absence seizures, hearing or visual impairment, thyroid disease, substance effects and normal developmental variation.
Comorbidity is the rule often enough to seek actively: oppositional or conduct problems, anxiety, depression, tics, autism, learning difficulties and substance use can alter treatment. Preschool management begins with parent-training and environmental intervention in ordinary pathways. Older children and adults may receive medication when impairment warrants it, but psychoeducation and contextual support remain necessary. Stimulants generally improve core symptoms more than academic skill itself; a pharmacological response does not prove the diagnosis.
Before medication, document mental and social review, misuse and diversion risk, current drugs, height and weight where age-appropriate, pulse, blood pressure and cardiovascular assessment. Routine ECG is not required in the absence of specified cardiac risk, but concerning history or examination prompts cardiology review. Monitor growth or weight, pulse, blood pressure, sleep, appetite, mood, tics, adherence and functional outcome during titration and maintenance. Modified-release stimulant preparations may reduce school-time dosing and some diversion opportunities, yet no formulation eliminates misuse. Transition to adult care must be planned. The examiner's safest answer links developmental diagnosis, multiple informants, comorbidity, functional goals and monitored treatment rather than choosing a tablet from a questionnaire score.
Frequently Asked Questions
Can a parent or teacher questionnaire confirm ADHD on its own?
No. A validated scale can organise symptom examples and monitor change, but diagnosis requires developmental history, impairment, more than one setting, observer information, mental-state and physical assessment, and consideration of alternatives and comorbidity. Different reports should be explored rather than averaged. Language, classroom expectations, stigma and who completed the form can influence scores.
Does doing well in examinations rule out attention-deficit/hyperactivity disorder?
No. Strong ability, family scaffolding, tutoring, intense last-minute effort or a highly structured environment may mask symptoms, while impairment appears in time management, sleep, relationships or emotional burden. Equally, poor marks alone do not prove ADHD and may reflect learning, language, sensory, mood, sleep or teaching problems. Diagnosis depends on the full developmental and functional pattern.
What monitoring is needed after ADHD medication is started?
The prescriber should track agreed symptoms and functional goals alongside adverse effects. Children need serial height and weight; adults need weight or BMI review when affected. Pulse and blood pressure are checked around dose changes and periodically, with review of appetite, sleep, mood, behaviour, tics, seizures, adherence, misuse and diversion. New serious cardiac or psychiatric symptoms need urgent assessment.
Can stimulant medicine be shared for studying or used to test whether someone has ADHD?
No. Stimulants are prescription medicines with cardiovascular, psychiatric, sleep, appetite, misuse and legal risks. A temporary increase in alertness does not diagnose ADHD. Sharing also removes clinical screening, dose titration and monitoring and may expose another person to harm. Store medicine securely and tell the prescriber about pressure to share, lost supplies, non-medical use or substance concerns without delaying urgent care.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic